Ecat, Julieta .
HRN: 05-20-50 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/09/2023
CEFTRIAXONE 1G (VIAL)
05/09/2023
05/16/2023
IV
2 Grams
OD
Cervical Mass Prob Sec To Metastatic Colon Cancers/ P Explore Lap, Diverting Colostomy
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes